Explore more publications!

Syria welcomes US Senate vote to repeal Caesar Act sanctions

(MENAFN) Syria on Wednesday expressed support for the US Senate’s decision to lift Caesar Act sanctions, according to reports.

In a post on the social media platform X, Syria’s foreign minister stated: “We express our sincere gratitude to the US Senate for its support to the Syrian people through its vote to repeal the Caesar Act.” He added that the move represents “a positive development that opens new horizons for cooperation and partnership between our country and the world.”

The announcement follows the Senate’s approval of the National Defense Authorization Act (NDAA), a $901 billion defense spending and policy bill for fiscal year 2026. The measure passed by a 77–20 vote and had already been approved by the House of Representatives earlier this month. It now awaits the US president’s signature, according to reports.

Key provisions in the legislation include the repeal of Caesar Act sanctions, which were imposed on Syria during the former Bashar al-Assad regime. The 2019 Caesar Syria Civilian Protection Act allowed the US to apply economic and travel sanctions on anyone, Syrian or foreign, supporting the Assad regime’s military, intelligence, aviation, or energy sectors, as well as individuals and entities facilitating the regime’s access to goods, services, or technologies that enable military operations.

MENAFN18122025000045017640ID1110495984


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions